Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
63 studies found for:    MIST2
Show Display Options
Rank Status Study
1 Completed
Has Results
Botulinum Toxin Injection for the Management of BPH
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: botulinum toxin type A (BoNT/A)
2 Completed Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects
Condition: Anesthesia
Interventions: Drug: 400uL of Kovacaine Mist;   Drug: 200uL of Kovacaine Mist;   Drug: 120uL of Kovacaine Mist
3 Completed Open-Label Study to Evaluate The Efficacy And Recommended Dosing Regimen Of Kovacaine Mist Administered Unilaterally For Anesthetizing Maxillary Teeth
Condition: Anesthesia
Interventions: Drug: Tetracaine HCl 3% and oxymetazoline HCl 0.05%;   Drug: Tetracaine HCl 3% and oxymetazoline HCl 0.05%
4 Completed Safety Study in Adolescent and Adult Patients With Asthma
Condition: Asthma
Interventions: Drug: Placebo;   Drug: Primatene Mist;   Drug: Epinephrine inhalation aerosol, HFA;   Drug: epinephrine inhalation aerosol
5 Completed Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin
Condition: Pseudomonas Infections
Intervention: Drug: tobramycin
6 Terminated Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.
Condition: Asthma
Interventions: Drug: E004 (epinephrine inhalation aerosol), 90 mcg/actuation;   Drug: E004 Placebo;   Drug: E004 (epinephrine inhalation aerosol), 125 mcg;   Drug: E004 (epinephrine inhalation aerosol), 220 mcg;   Drug: epinephrine inhalation aerosol, CFC propelled;   Drug: E004 (epinephrine inhalation aerosol), 160 mcg
7 Recruiting Aerosol IL-2 for Pulmonary Metastases
Conditions: Sarcoma;   Solid Tumors;   Pulmonary Metastases;   Lung Metastases;   Osteosarcomas;   Ewing Sarcoma
Interventions: Drug: Aerosol IL-2;   Procedure: Symptom Assessment
8 Completed
Has Results
Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
Condition: Asthma
Intervention: Drug: epinephrine inhalation aerosol
9 Completed Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects
Condition: Anesthesia
Intervention: Drug: Tetracaine HCl 3% and Oxymetazoline HCl 0.05%
10 Completed
Has Results
Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
Conditions: Asthma;   Bronchospasm;   Wheezing;   Shortness of Breath
Interventions: Drug: Epinephrine Inhalation Aerosol, HFA;   Drug: Epinephrine Inhalation Aerosol
Condition: Asthma
Interventions: Drug: Treatment arm T1;   Drug: Treatment arm T2;   Drug: Treatment arm C
12 Completed
Has Results
Safety Study to Evaluate FluMist in Immunocompromised Children
Condition: Cancer
Interventions: Biological: FluMist;   Biological: Placebo
13 Recruiting Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia
Condition: Frontotemporal Dementia
Interventions: Drug: Intranasal oxytocin;   Drug: Saline Nasal Mist
14 Completed
Has Results
Childhood Asthma Research and Education (CARE) Network Trial - Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)
Condition: Asthma
Interventions: Drug: Budesonide;   Drug: Placebo Budesonide
15 Completed Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)
Condition: Anesthesia
Intervention: Drug: Tetracaine HCl 3% and Oxymetazoline HCl 0.05%
16 Recruiting Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age
Condition: Asthma
Interventions: Device: Standard nebulizer;   Device: PARI LC Sprint Sp nebulizer
17 Completed Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Condition: Asthma
Interventions: Drug: Epinephrine inhalation aerosol;   Drug: Placebo;   Drug: epinephrine inhalation aerosol
18 Completed Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults
Condition: Influenza
Interventions: Biological: FluMist;   Other: Placebo
19 Active, not recruiting Evaluate the Immunogenicity of a Novel Glucagon Formulation
Conditions: Drug-specific Antibodies;   Hypoglycemia;   Diabetes Mellitus
Interventions: Drug: Glucagon IN;   Drug: Glucagon IM
20 Completed
Has Results
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium 18 mcg;   Drug: tiotropium 1.25 mcg (2 actuations/day);   Drug: tiotropium 2.5 mcg (2 actuations/day)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years